GNI Group Ltd. has been newly selected in TOPIX's periodic constituent reshuffle following the market reforms and will move from the Growth Market into TOPIX. The company is expected to attract greater interest from institutional investors in Japan and overseas.
GNI Group Ltd. has been selected as a TOPIX constituent and is scheduled to be included in the index from 30 October 2026. The selection marks the first periodic constituent reshuffle under the second phase of TOPIX reforms.
Assets tracking TOPIX have grown to approximately ¥140 trillion, and the company's inclusion will broaden the universe of assets available to index-tracking strategies. This is expected to increase the company's exposure to long-term holdings and research coverage by institutional investors in Japan and overseas through ETFs and index funds.
GNI Group Ltd. CEO Dr. Yin Luo said he considers the company's selection as a TOPIX constituent in the first periodic reshuffle following the reforms significant. He also indicated that the company aims to achieve global business growth and enhance corporate value, following the completion in July 2026 of its acquisition of ayumi製薬, including Caronal, which strengthened its sales platform in Japan.